Article Text

PDF
The authors’ reply
  1. P A Brady,
  2. G Lin
  1. Heart Rhythm Services, Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN, USA
  1. Dr Peter Brady, Heart Rhythm Services, Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN, USA; brady.peter{at}mayo.edu

Statistics from Altmetric.com

We appreciate the opportunity to respond to each of the points raised by Cleland et al as follows: First, we reject the implication that patient care focused on CRT rather than appropriate pharmacological therapy. In fact, all patients were on maximum tolerated medical therapy and were referred for a CRT device following careful clinical review and met accepted implant criterion. The fact that many patients could not tolerate higher doses …

View Full Text

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles